127 related articles for article (PubMed ID: 30686519)
1. Diagnostic and prognostic utility of SF1, IGF2 and p57 immunoexpression in pediatric adrenal cortical tumors.
Guntiboina VA; Sengupta M; Islam N; Barman S; Biswas SK; Chatterjee U; Mishra PK; Roy P; Mallick MG; Datta C
J Pediatr Surg; 2019 Sep; 54(9):1906-1912. PubMed ID: 30686519
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic role of SF1, IGF2, Ki67, p53, adiponectin, and leptin receptors in human adrenal cortical tumors.
Babińska A; Pęksa R; Wiśniewski P; Świątkowska-Stodulska R; Sworczak K
J Surg Oncol; 2017 Sep; 116(3):427-433. PubMed ID: 28672049
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic utility of SF-1 in adrenal cortical tumours.
Maity P; Mondal A; Das R; Sengupta M; Gargari P; Kar A; Sarkar D; Mukhopadhyay S; Chowdhury S; Chatterjee U
Indian J Pathol Microbiol; 2022; 65(4):814-820. PubMed ID: 36308186
[TBL] [Abstract][Full Text] [Related]
4. Weineke criteria, Ki-67 index and p53 status to study pediatric adrenocortical tumors: Is there a correlation?
Das S; Sengupta M; Islam N; Roy P; Datta C; Mishra PK; Banerjee S; Chaudhuri MK; Chatterjee U
J Pediatr Surg; 2016 Nov; 51(11):1795-1800. PubMed ID: 27567308
[TBL] [Abstract][Full Text] [Related]
5. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
[TBL] [Abstract][Full Text] [Related]
6. IGF2 role in adrenocortical carcinoma biology.
Pereira SS; Monteiro MP; Costa MM; Moreira Â; Alves MG; Oliveira PF; Jarak I; Pignatelli D
Endocrine; 2019 Nov; 66(2):326-337. PubMed ID: 31378849
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and Prognostic Biomarkers of Adrenal Cortical Carcinoma.
Mete O; Gucer H; Kefeli M; Asa SL
Am J Surg Pathol; 2018 Feb; 42(2):201-213. PubMed ID: 28877067
[TBL] [Abstract][Full Text] [Related]
8. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.
Mete O; Erickson LA; Juhlin CC; de Krijger RR; Sasano H; Volante M; Papotti MG
Endocr Pathol; 2022 Mar; 33(1):155-196. PubMed ID: 35288842
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor system on adrenocortical tumorigenesis.
Ribeiro TC; Latronico AC
Mol Cell Endocrinol; 2012 Mar; 351(1):96-100. PubMed ID: 22019903
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas.
Morimoto R; Satoh F; Murakami O; Suzuki T; Abe T; Tanemoto M; Abe M; Uruno A; Ishidoya S; Arai Y; Takahashi K; Sasano H; Ito S
Endocr J; 2008 Mar; 55(1):49-55. PubMed ID: 18187873
[TBL] [Abstract][Full Text] [Related]
11. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.
Soon PS; Gill AJ; Benn DE; Clarkson A; Robinson BG; McDonald KL; Sidhu SB
Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers.
Wang C; Sun Y; Wu H; Zhao D; Chen J
Histopathology; 2014 Mar; 64(4):567-76. PubMed ID: 24102952
[TBL] [Abstract][Full Text] [Related]
13. Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression.
Wilkin F; Gagné N; Paquette J; Oligny LL; Deal C
J Clin Endocrinol Metab; 2000 May; 85(5):2048-56. PubMed ID: 10843195
[TBL] [Abstract][Full Text] [Related]
14. Correlation between selected angiogenic markers and prognosis in pediatric adrenocortical tumors: Angiogenic markers and prognosis in pediatric ACTs.
Dias AI; Fachin CG; Avó LR; Frazão CV; Caran EM; Schettini ST; Alves MT; Ribeiro RC; Abib Sde C
J Pediatr Surg; 2015 Aug; 50(8):1323-8. PubMed ID: 25783314
[TBL] [Abstract][Full Text] [Related]
15. IGF2 and IGF1R in pediatric adrenocortical tumors: roles in metastasis and steroidogenesis.
Peixoto Lira RC; Fedatto PF; Marco Antonio DS; Leal LF; Martinelli CE; de Castro M; Tucci S; Neder L; Ramalho L; Seidinger AL; Cardinalli I; Mastellaro MJ; Yunes JA; Brandalise SR; Tone LG; Rauber Antonini SR; Scrideli CA
Endocr Relat Cancer; 2016 Jun; 23(6):481-93. PubMed ID: 27185872
[TBL] [Abstract][Full Text] [Related]
16. DAX1 Overexpression in Pediatric Adrenocortical Tumors: A Synergic Role with SF1 in Tumorigenesis.
de Sousa GR; Soares IC; Faria AM; Domingues VB; Wakamatsu A; Lerario AM; Alves VA; Zerbini MC; Mendonca BB; Fragoso MC; Latronico AC; Almeida MQ
Horm Metab Res; 2015 Aug; 47(9):656-61. PubMed ID: 25985323
[TBL] [Abstract][Full Text] [Related]
17. Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults.
Faria AM; Almeida MQ
Mol Cell Endocrinol; 2012 Mar; 351(1):52-7. PubMed ID: 22019901
[TBL] [Abstract][Full Text] [Related]
18. Classification of adrenal cortical tumors: what limits for the pathological approach?
Tissier F
Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):877-85. PubMed ID: 21115156
[TBL] [Abstract][Full Text] [Related]
19. Pediatric adrenocortical neoplasms: immunohistochemical expression of p57 identifies loss of heterozygosity and abnormal imprinting of the 11p15.5.
Giovannoni I; Boldrini R; Benedetti MC; Inserra A; De Pasquale MD; Francalanci P
Pediatr Res; 2017 Mar; 81(3):468-472. PubMed ID: 27842055
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of Wieneke criteria in assessing morphologic characteristics of adrenocortical tumors in children.
Chatterjee G; DasGupta S; Mukherjee G; Sengupta M; Roy P; Arun I; Datta C; Mishra PK; Banerjee S; Chatterjee U
Pediatr Surg Int; 2015 Jun; 31(6):563-71. PubMed ID: 25895073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
